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Abstract
Studies of human trisomies indicate a remarkable relationship between abnormal meiotic recombination and subsequent
nondisjunction at maternal meiosis I or II. Specifically, failure to recombine or recombination events located either too near
to or too far from the centromere have been linked to the origin of human trisomies. It should be possible to identify these
abnormal crossover configurations by using immunofluorescence methodology to directly examine the meiotic
recombination process in the human female. Accordingly, we initiated studies of crossover-associated proteins (e.g.,
MLH1) in human fetal oocytes to analyze their number and distribution on nondisjunction-prone human chromosomes and,
more generally, to characterize genome-wide levels of recombination in the human female. Our analyses indicate that the
number of MLH1 foci is lower than predicted from genetic linkage analysis, but its localization pattern conforms to that
expected for a crossover-associated protein. In studies of individual chromosomes, our observations provide evidence for
the presence of ‘‘vulnerable’’ crossover configurations in the fetal oocyte, consistent with the idea that these are
subsequently translated into nondisjunctional events in the adult oocyte.
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Introduction
Meiotic errors generate an extraordinary number of chromo-
some abnormalities in humans, with most of the abnormalities
originating in the first meiotic division in the oocyte [1]. Studies
conducted over the past 10–20 years have identified the first
molecular correlate of these abnormalities, as disturbances in
meiotic recombination have been linked to a variety of human
trisomies of maternal origin [1]. Specifically, reductions in
recombination have been associated with nondisjunction of
chromosomes 13, 15, 16, 18, 21, 22 and the sex chromosomes
[2,3,4,5,6,7,8,9,10], and alterations in the location of crossover
events with trisomies 16 and 21 and sex chromosome trisomies
[5,8,10]. These associations are consistent with similar observations
in model organisms such as Drosophila [11] and S. cerevisiae [12],
but the magnitude of the effect in humans has been surprising. For
example, the majority of cases of trisomy 21 appear to be
attributable to failure to crossover, or to crossovers located too
close to, or too far away from, the centromere [13]. Similarly, most
cases of trisomy 16 are associated with distally located exchanges
[5]. Thus, it appears that a large proportion, if not a majority, of
human trisomies involve achiasmate homologous chromosomes, or
homologous chromosomes with sub-optimally located exchanges.
These observations present a conundrum. That is, how can
aberrant meiotic recombination, an event that occurs in the fetal
ovary, be a major contributor to trisomy when advancing
maternal age, a process that occurs decades later, is unquestion-
ably the most important risk factor for meiotic nondisjunction?
The answer is not yet obvious, but several groups have suggested
that there is a two-step process that links the two etiological factors
[14]. Specifically, it is assumed that a proportion of homologs are
either achiasmate or tethered by sub-optimally located crossovers.
With increasing maternal age, these configurations become more
likely to nondisjoin. If this is the case, at least two predictions
follow: First, for older women, chromosome-specific genetic maps
constructed from analyses of trisomic conceptions should be
shorter, and with a different distribution of exchanges, than those
from chromosomally normal offspring. Second, direct analyses of
crossover events in human fetal oocytes should reveal ‘‘vulnerable’’
crossover configurations that should exhibit chromosome specific-
ity consistent with data from trisomic conceptions (e.g., for
chromosome 16, distally located exchanges and for chromosome
21, proximal and distal exchanges, as well as achiasmate
chromosomes).
Over the past several years, a number of groups have attempted
to address the first prediction, examining the relationship between
crossing-over patterns and maternal age in trisomic conceptions
(e.g., [3,4,8,15]). However, there has been little attempt to address
the second prediction. In part this is attributable to the obvious
challenges in obtaining the appropriate study material (i.e.,
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importantly, there has been no simple approach to visualize the
crossing-over process. The introduction of immunofluorescence
methodology eliminates this problem and provides a simple,
straightforward approach to the analysis of human meiosis,
making it possible to monitor the formation of meiosis-specific
structures (e.g., the synaptonemal complex, SC) and to visualize
interactions between homologs as they pair, synapse and
recombine during meiotic prophase. Of particular importance
has been the employment of the MutL homologue, MLH1, to
identify the sites of crossovers on meiotic chromosomes. Studies of
male and female mice and human males indicate a 1:1
correspondence between the occurrence of MLH1 foci in
pachytene spermatocytes/oocytes and sites of chiasmata in
diakinesis stage cells or sites of recombination inferred from
genetic linkage studies (for review, see [16]). Consequently, by
using MLH1 as a surrogate for exchanges, it now seems possible to
analyze crossing-over ‘‘as it happens’’ during pachytene. Further,
the inclusion of chromosome-specific fluorescence in situ hybrid-
ization (FISH) in such investigations provides a means to monitor
recombination on individual chromosomes.
Utilizing this approach, several groups have initiated studies of
human female meiosis [17,18,19,20] but in most of these the focus
has been on the meiotic process, and not specifically on
recombination. Thus, we recently initiated studies utilizing human
fetal ovarian samples. We evaluated the utility of MLH1 as a
marker of crossing-over in females and asked whether achiasmate
chromosomes and sub-optimal crossover patterns are, indeed, a
feature of human female meiosis. In this report we summarize
results on an initial series of 1035 prophase oocytes from 31 fetal
ovarian samples. Our results provide evidence of temporal
differences between human males and females in the appearance
of MLH1 foci on the synaptonemal complex, but indicate that
MLH1 foci are a useful marker of crossovers in females as well as
males. The results of analyses of the number and location of
MLH1 foci provide evidence for the presence of ‘‘vulnerable’’
crossover configurations, observations consistent with data from
previous human trisomy studies.
Results
Preparations of prophase oocytes were made from 31 fetal
ovarian samples collected from female fetuses with gestational ages
between 14–23 weeks. A summary of the information on these
cases is provided in Table 1.
Temporal aspects of MLH1 localization
In previous studies of human males [20,21,22], mouse males
[23,24] and mouse females [25], MLH1 has been observed to
localize primarily to SCs of pachytene stage cells. However, similar
immunostaining studies of human fetal oocytes have suggested a
more ‘‘relaxed’’temporalpattern,withMLH1focievidentinearlier
meiotic stages [17,26]. Thus, in initial analyses, we were interested
inexaminingthe temporalpatternofMLH1 localization inour own
series. Representative images of leptotene, zygotene and pachytene
cells are provided in Figure 1A–1C. At leptotene (Figure 1A),
MLH1 foci were occasionally observed as small, dispersed signals
throughout the nucleus, but it was unclear whether these were
actually associated with SCs. However, at zygotene (Figure 1B), SC-
associated MLH1 foci were clearly visible in all cases that we
examined,althoughthesignals werenotnearlyas intenseas thosein
later pachytene stage cells (Figure 1C). We made no systematic
attempt to quantify the number of foci present in zygotene cells, but
in general they were less abundant than in pachytene cells.
Analyses of recombination over the entire genome
Table 2 provides a summary of the mean genome-wide MLH1
countspercellforthe31ovariansamples(seeFigureS1forgraphical
representation of the data). The overall mean MLH1 value per cell
for the 1035 pachytene cells we examined was 69.3614.3. However,
there was considerable variation within and among individual
ovarian samples. For example, for most ovaries there was an
approximate two-fold difference between the lowest and highest
MLH1 values. Similarly, there was highly significant variation
among the 31 samples (F=19.0; p,0.0001), with individual mean
valuesranging from alowof52.6(SF 009) toa highof88.3(EC101).
This variation was not attributable to either gestational or maternal
age, as we saw no obvious relationship between MLH1 counts and
these variables. Further, there was no obvious effect of fetal
abnormalities (i.e., identified in cases EC 41, 69, 76, 96 and 98;
Table 1) on the number or distribution of MLH1 foci.
In a second analysis, we were interested in determining the
number of cells in which there were one or more chromosomes
without MLH1 foci (assuming a 1:1 correspondence between
MLH1 foci and crossovers, such situations would yield achiasmate
chromosomes at metaphase/anaphase I). This assessment was
complicated by the length of the individual SCs, which resulted in
numerous overlapping SCs in most cells. Nevertheless, we were
able to independently visualize all 23 SCs in 176 (17.0%) of the
1035 cells; Figure 1C provides an example of one such cell. In the
vast majority (132/176=75.0%) of these cells, MLH1 foci were
detected on all bivalents. However, in 31 cells we observed a single
‘‘MLH1-less’’ bivalent, in 9 cells two of the SCs were lacking
MLH1 foci, in one cell 3 bivalents were without foci and in one
cell 6 SCs were lacking foci. We made no attempt to identify the
specific MLH1-less chromosomes using FISH; however, on the
basis of morphology, exactly one-half involved small acrocentric
chromosomes (i.e., either chromosomes 21 or 22), with no other
chromosome group being obviously over-represented.
Chromosome-specific recombination studies
In subsequent studies, we were interested in assessing recombi-
nation patterns on chromosomes known to be associated with
Author Summary
One of the defining events in the formation of eggs and
sperm is meiotic recombination, a process in which DNA is
exchanged between ‘‘partner’’ chromosomes. If this
process is perturbed, chromosomes often go astray during
meiotic division, resulting in eggs or sperm with too many
or too few chromosomes. In humans, the resulting
embryos are almost always abnormal and are a major
source of miscarriages or congenital birth defects (e.g.,
Down syndrome). Over the past decade, techniques have
become available that make possible the examination of
meiotic recombination ‘‘as it happens’’ in the human egg,
and this has allowed us to define the properties of this
process. In the present study, we used this methodology
to characterize meiotic recombination in human fetal
oocytes and to ask whether we could identify abnormal
recombination patterns. Such patterns were, indeed,
observed for each chromosome we studied, although
different abnormalities were observed among the individ-
ual chromosomes. Thus, factors operating before birth
influence the likelihood of chromosome misdivision in the
adult oocyte, although those that make chromosome 21
misdivide (leading to Down syndrome) may not be the
same as those that make other chromosomes misdivide.
Recombination in Human Oocytes
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ID Maternal Age (years) Gestational Age (weeks) Clinical Observations/Reason for Ascertainment Chromosome Constitution
EC 010 18 46,XX
EC 018 22 46,XX
EC 041 16 anencephaly
EC 053 16
EC 069 20 multiple congenital anomalies 46,XX
EC 076 19 neurotube defect
EC 091 21
EC 096 20 renal agenesis with anhydramnios 46,XX
EC 098 17 anencephaly
EC 099 19
EC 101 20 maternal vaginal lymphoma
SF 001 21 20 elective termination
SF 002 21 21 elective termination
SF 004 27 20 elective termination
EC 141 15
SF 008 25 19 elective termination
EC 143 14
SF 009 31 23 elective termination
EC 147 18 placenta accreta
SF 010 30 19 elective termination
SF 011 18 23 elective termination
SF 012 29 22 elective termination
SF 013 21 15 elective termination
SF 018 32 23 elective termination
SF 020 31 19 elective termination
SF 023 18 21 elective termination
SF 024 37 19 elective termination
SF 025 21 19 elective termination
SF 029 16 23 elective termination
SF 032 24 22 elective termination
SF 035 19 20 elective termination
doi:10.1371/journal.pgen.1000661.t001
Figure 1. Representative images from (A) leptotene, (B) zygotene, and (C) pachytene stage human fetal oocytes. Antibodies against
SYCP3 (representing the axial elements of the synaptonemal complex) are visualized in red and against the DNA mismatch repair protein MLH1 in
green, and CREST antiserum-positive signals (recognizing centromeric regions) are visualized in blue.
doi:10.1371/journal.pgen.1000661.g001
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somes associated with clinical syndromes (i.e., trisomies 13, 18 and
21), or high frequencies of occurrence inspontaneous abortions (i.e.,
trisomies 16 and 22); additionally, we included chromosome 17 as a
‘‘comparison’’ for the other E group chromosomes (i.e., chromo-
somes 16 and 18). Cumulatively, these six chromosomes account for
well over 50% of all clinically recognized trisomies [27].
For these analyses, we examined slides from a subset of the study
population (i.e., cases EC 69, 76, 91, 96, 98, 99 and 101). These
cases were not selected in any way, but instead represented seven
consecutive samples collected at the time at which we were
interested in conducting this specific analysis. The pooled genome-
wide MLH1 mean value for these seven cases was slightly higher
than for the general study population (i.e., 77.9 vs. 69.3). However,
the data on the individual chromosomes was similar among the
seven cases, despite the fact that the mean MLH1 values varied
from 68.2 to 88.3; additionally, the proportion of achiasmate
chromosomes for these individuals was similar to that observed for
individuals in the general series. Thus it seems likelythat, in general,
the data are representative of the study population as a whole.
Chromosome-specific genetic lengths. Table 3 shows the
number of MLH1 foci per bivalent and the estimated genetic
lengths (assuming that one MLH1 focus=one crossover=50 cM)
for chromosomes 13, 16, 17, 18, 21 and 22. The overall number of
MLH1 foci was virtually identical for SCs of chromosomes 13, 16
and 17, with each averaging approximately 2.5 foci per bivalent.
The number of foci was slightly reduced for chromosome 18, at
2.2 foci, and chromosomes 21 and 22 each averaged slightly more
than one focus, with chromosome 22 somewhat higher than
chromosome 21.
In general, we found that most chromosome arms possessed at
least one MLH1 focus (Table 4). The most notable exceptions
were the short arms of the acrocentric chromosomes (13, 21 and
22), on which foci were detected in only 11/412 cells (2.7%).
Additionally, the short arm of chromosome 18 exhibited a
surprisingly high proportion of ‘‘MLH1-less’’ events, as in 42/
112 cells (37.5%) either both the p and q arms or the p arm lacked
MLH1 foci. This contrasted sharply with the other two E group
chromosomes, as for chromosomes 16 and 17 the frequencies of
MLH1-less short arms were 0% and 18.3%, respectively.
Chromosomal location of MLH1 foci. Figure 2, Figure 3,
Figure 4, Figure 5, Figure 6, and Figure 7 show the approximate
location of MLH1 foci, ordered by the number of MLH1 foci per
SC, for chromosomes 13, 16, 17, 18, 21 and 22 (Figure S2, S3, S4,
S5, S6, S7 show the same information, but with the data pooled by
the number of MLH1 foci per SC). For this analysis, we simply
divided the chromosome arms into five equal segments, and
specified the segmental location for each MLH1 focus. Clearly,
this only provides a general assessment of MLH1 localization,
since it does not take into account the variation in arm-arm
physical lengths for individual chromosomes. Nevertheless, it
provides a mechanism for generating initial cytological maps and
for examining spatial relationships between foci that are located on
the same chromosomes.
For most chromosome arms, interstitial locations predominated,
with the highest proportion of MLH1 foci being medially placed.
That is, excluding the short arms of the acrocentric chromosomes,
the proportion of foci located in the ‘‘middle’’ segment exceeded
the predicted 20% assuming random placement, and typically
accounted for between 30% and 60% of foci per arm (Figure S2,
S3, S4, S5, S6, S7). In contrast, telomeric and centromeric foci
were under-represented on almost all chromosome arms, with
each region typically accounting for 10% or fewer of all foci.
Chromosome 16 provided the one notable exception to this trend.
Specifically, on 16q the highest proportion of MLH1 foci (29%)
was located in the most telomeric region; further, the proportion of
telomeric foci on 16p (16%) was only slightly less than the 20%
expectation and was higher than that observed for any other
chromosome arm except 16q.
In a separate analysis, we examined the spacing of MLH1 foci
on bivalents with two or more foci. For each of the six
chromosomes, the placement of foci was clearly non-random,
consistent with strong positive interference (Figure 2, Figure 3,
Figure 4, Figure 5, Figure 6, Figure 7). For example, in the
simplest situation – SCs with exactly two MLH1 foci – the two foci
were never observed in the same region (i.e., 0/238 SCs involving
chromosomes 13, 16, 17, 18, 21 or 22). Subsequently, we
examined interference more directly by estimating coincidence
values over different interval distances for each of the chromo-
somes (Figure 8). When all SCs with multiple foci were considered,
estimates of coincidence indicated significant positive interference
over one to three chromosome regions. The relative distance over
Table 2. Summary of MLH1 analyses from 31 fetal ovarian
samples.
ID Number of Cells Mean MLH1 Count6S.D. Range
EC 010 25 59.3610.0 43–81
EC 018 7 80.7618.1 53–96
EC 041 71 65.1611.5 40–89
EC 053 14 69.8612.4 46–89
EC 069 40 68.268.8 44–83
EC 076 36 71.7610.9 54–95
EC 091 39 68.669.4 49–92
EC 096 60 79.6610.7 59–102
EC 098 30 82.1610.2 57–107
EC 099 37 87.1616.0 50–115
EC 101 53 88.3610.3 66–109
SF 001 59 59.2614.0 27–89
SF 002 34 59.7610.4 37–74
SF 004 17 59.1613.9 40–96
EC 141 13 76.3614.1 58–94
SF 008 70 66.6611.6 42–92
EC 143 11 87.2611.1 64–104
SF 009 13 52.6610.5 40–61
EC 147 40 67.8611.0 48–88
SF 010 54 65.5612.8 45–100
SF 011 10 75.068.8 55–89
SF 012 10 64.868.0 52–76
SF 013 40 66.4613.9 43–97
SF 018 12 72.2614.6 56–107
SF 020 11 60.2610.8 48–74
SF 023 20 64.3612.6 45–86
SF 024 39 61.8610.8 45–84
SF 025 46 59.969.7 43–77
SF 029 18 69.6610.9 55–92
SF 032 50 73.3611.6 51–103
SF 035 56 69.9610.3 50–100
Total 1035 69.3614.3 27–107
doi:10.1371/journal.pgen.1000661.t002
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somes; i.e. estimates of coincidence significantly ,1.0 were
observed over three adjacent intervals for chromosome 13, over
two intervals for chromosomes 16, 17 and 18, and over one
interval for chromosomes 21 and 22 (Figure 8).
We were also interested in determining whether interference
acted across the centromere, or whether the positioning of MLH1
foci on one chromosome arm was independent of focus location on
the other arm. For this analysis, we examined the three non-
acrocentric chromosomes (i.e., 16, 17 and 18), analyzing all
situations in which adjacent MLH1 foci were located on opposite
chromosome arms. Specifically, we analyzed the distribution of
MLH1 foci on the short arm by the location of the adjacent long
arm focus; for both arms, we collapsed the five segments
(centromeric, proximal, medial, distal, telomeric) into three
because of the relatively small number of centromeric and
telomeric MLH1 foci (Figure 9). The short arm localization
patterns were highly significantly different for the three categories
(x2=20.4; p,0.001), with distal/telomeric short arm foci more
likely to be observed in association with centromeric/proximal
long arm foci than with distal/telomeric long arm foci. Thus, we
conclude that interference operates over the centromere.
Discussion
The purpose of the present study was threefold: 1) to determine
whether analysis of MLH1 foci in pachytene oocytes could provide
a reliable approach to studying human female recombination and
if so; 2), to use this approach to characterize basic features of
female recombination and; 3), to determine whether ‘‘vulnerable’’
chiasma configurations predicted by the two hit model of human
nondisjunction [28] are evident in pachytene oocytes.
Are MLH1 foci reliable markers of crossovers in human
ooocytes?
Over the past several years, analyses of pachytene stage
meiocytes from human males, mouse males and mouse females
have demonstrated a remarkable correlation between the number
Table 3. Number of MLH1 foci on individual chromosomes.
Chromosome (number cells) Number exchanges (%) Mean/cell Genetic length (cM)
0123456
13 (104) 1 8 42 39 12 2 – 2.57 128.4
(1.0) (7.7) (40.4) (37.5) (11.5) (1.9) –
16 (73) – 5 30 35 3 – – 2.49 124.5
– (6.8) (41.1) (47.9) (4.1) – –
1 7 ( 9 8 ) 11 2 3 1 4 2 9212 . 5 7 1 2 8 . 6
(1.0) (12.2) (31.6) (42.9) (9.2) (2.0) (1.0)
18 (112) 3 17 53 30 8 1 – 2.23 111.6
(2.7) (15.2) (47.3) (26.8) (7.1) (0.9) –
2 1 ( 1 6 4 ) 81 1 5 4 0 1–––1 . 2 1 6 0 . 4
(4.9) (70.1) (24.4) (0.6) – – –
2 2 ( 1 4 4 ) 98 7 4 1 7–––1 . 3 2 6 6 . 0
(6.3) (60.4) (28.5) (4.9) – – –
doi:10.1371/journal.pgen.1000661.t003
Table 4. Presence or absence of exchanges on arms of individual chromosomes.
Chromosome (no cells) Presence (+) or absence (2) of MLH1 focus(i) on individual arms of bivalent
pa r m 2/q arm2 pa r m +/q arm2 pa r m 2/q arm+ pa r m +/q arm+
13 (104) no. 1 0 99 4
(%) (1.0) (0.0) (95.2) (3.8)
16 (73) no. 0 5 4 64
(%) (0.0) (6.8) (5.5) (87.7)
17 (98) no. 1 5 17 75
(%) (1.0) (5.1) (17.3) (76.5)
18 (112) no. 3 3 39 67
(%) (2.7) (2.7) (34.8) (59.8)
21 (164) no. 8 2 152 2
(%) (4.9) (1.2) (92.7) (1.2)
22 (144) no. 9 0 132 3
(%) (6.3) (0.0) (90.3) (2.1)
doi:10.1371/journal.pgen.1000661.t004
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meiotic recombination events (e.g., [21,23]). Thus, a number of
laboratories, including our own, have assumed that MLH1 foci
mark the sites of crossovers. However, the evidence that MLH1
localizes to sites of recombination in human female oocytes is not
as convincing. For example, both Lenzi et al [17] and Hulten and
colleagues [26] have reported lower average MLH1 counts per
oocyte than those predicted from genetic linkage analyses of
human females (Table 5).
The results of the present study are in good agreement with
these previous immunostaining studies. In our series the overall
mean number of MLH1 foci per oocyte was 69.3, corresponding
to a genome-wide genetic length of 3465 cM. As estimates from
linkage analyses indicate a female genome-wide length of
approximately 4300–4600 cm [29,30,31,32,33,34] it means that
– similar to the previous immunostaining studies – we may have
‘‘missed’’ approximately 20% of all recombination events.
The reason for this discrepancy is not clear; however, we can
think of at least four possible explanations why MLH1-based
studies may have underestimated the ‘‘real’’ number of exchanges.
First, it could be that these studies selected a sub-set of cells that
are unrepresentative of all pachytene stage oocytes. For example,
in the present analysis, we excluded cells with obvious synaptic
defects. However, since such cells typically contain fewer, not
more, MLH1 foci (data not shown), this seems an unlikely
explanation. Second, it could be that the discrepancy is
attributable to differential selection against a sub-set of oocytes.
For example, it may be that, in the human female, the prenatal
wave of oocyte atresia is more likely to involve oocytes with low
numbers of exchanges so that, on average, oocytes that survive to
be ovulated have more exchanges than pachytene stage human
fetal oocytes. However, this does not explain the fact that oocyte
atresia in female mice does not produce obvious differences in
results between MLH1-based assays of recombination and genetic
linkage analyses [25,35]. Third, the discrepancy may reflect the
existence of other, non-MLH1-associated crossover pathways.
Indeed, non-interfering crossover pathways that are independent
of MLH1 have been described in multiple organisms (e.g.,
[36,37]), and appear to exist in mammals as well [38]. However,
they seem unlikely to play a major role in crossover formation.
Cytological [39] and molecular studies [40,41] of mice homozy-
gous for mutations in MLH1 (or its partner MLH3) suggest that
only a small number (10% or less) of crossovers occur in the
absence of the MLH1-associated pathway. Thus, while other non
MLH1-driven crossover pathways almost certainly contribute to
the discrepancy, they provide at best only a partial explanation.
Finally, the discrepancy may reflect biological differences in the
recombination pathway between human females and human
males and mice. In our experience, MLH1 foci are rarely
visualized before pachytene in human and mouse males, and are
also infrequent in mouse females. In contrast, we and others
[17,26] have observed abundant MLH1 localization in both
zygotene and pachytene stage human oocytes, suggesting that
crossing-over occurs over a wider temporal window in the human
female. If so, crossovers may not be established synchronously in
human oocytes, meaning that it will be difficult to visualize all
MLH1 foci at the same time. Thus, MLH1 foci would mark
exchanges in human oocytes as in human males and mice but, at
any given time, not all exchanges would be identifiable.
We favor this last explanation, since it is the only one that fits
our observations. Nevertheless, the suggestion of a fundamental
difference in the chronology of recombination between human
males and females – and between human females and mice –
clearly requires confirmation. Initially, it will be important to
assess the localization patterns of other recombination proteins in
human males and females, and ask whether there are other
consistent sex-specific differences.
Regardless of the correctness of this or any of the other possible
explanations, one conclusion seems clear – some proportion of
exchanges are unrepresented by the MLH1 methodology. Thus it
is important that we judiciously interpret MLH1-based data on
human female recombination. For example, MLH1 analysis
presumably over-estimates the number of achiasmate bivalents,
one of the ‘‘vulnerable’’ chiasma configurations associated with
models of human nondisjunction. Further, inferences about
interference will be complicated by the fact that some exchanges
Figure 2. Chromosomal locations of MLH1 foci on chromosome 13 (Figure 2), considered by the number of MLH1 foci per SC.
doi:10.1371/journal.pgen.1000661.g002
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somal locations of exchanges. We do not take this to mean that the
MLH1-based approach is without merit. Indeed, by comparison
with other approaches (e.g., genetic linkage analysis, diakinesis
studies of chiasmata), it may provide the most straightforward
approach to capturing the vast majority of exchanges in human
females. Nevertheless, it does not provide the apparent 1:1
correspondence that has been observed between MLH1 foci and
crossovers in human males and mice.
What do MLH1 studies tell us about meiotic
recombination patterns in human females?
Despite concerns about the utility of the MLH1 approach, the
number and distribution of MLH1 foci in pachytene oocytes
conformed to two basic principles of meiosis common to most
species: first, the presence of at least one exchange per bivalent and
second, the non-random positioning of exchanges on chromo-
somes.
Most importantly, in our analyses virtually all chromosomes
contained at least one MLH1 focus. In the 176 cells in which we
were able to analyze the number of MLH1 foci on all 23 bivalents,
we identified only 57 MLH1-less bivalents. Considered on a per
chromosome basis, this means that only 1.4% (57/4048) of all
bivalents lacked an MLH1 focus. Subsequent analyses of individual
chromosomes 13, 16, 17, 18, 21 and 22 were consistent with the
genome-wide observations. Specifically, the proportion of MLH1-
less bivalents ranged from a low of 0% for chromosome 16 to highs
of approximately 5–6% for chromosomes 21 and 22 (Table 3).
Whilewe didnotsystematically studyindividualchromosomes1–12
or the X chromosome, limited analyses of these chromosomes
provided little evidence of MLH1-less bivalents (data not shown);
thus in our series the values for chromosomes 21 and 22 are
undoubtedly the highest for any chromosomes.
Our observations also provide strong evidence for a non-
random distribution of exchanges on chromosomes. First, the
number of MLH1 foci per chromosome was constrained. For
example, for the smallest chromosomes (i.e., 21 and 22), virtually
all bivalents had either one or two MLH1 foci, while for
chromosomes 13, 16, 17 and 18 the vast majority had two, three
or four foci. Second, for each of the six individual chromosomes
analyzed, the foci were spread out along the chromosomes; i.e.,
their placement was consistent with positive crossover interference
Figure 3. Chromosomal locations of MLH1 foci on chromosome 16, considered by the number of MLH1 foci per SC.
doi:10.1371/journal.pgen.1000661.g003
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males [42] and with previous linkage analyses [43], we found no
evidence that interference was impeded by the centromere.
The number and distribution of MLH1 foci also recapitulated
several observations from human genetic linkage analyses and
cytological analyses of recombination. For example, despite our
conclusion that we missed some exchanges, the mean number of
MLH1 foci per oocyte was still far in excess of that reported for
human pachytene spermatocytes (i.e., approximately 50 per cell;
[22]). Thus, in agreement with evidence from genetic linkage
studies (e.g., [44]), our analyses indicate that meiotic recombina-
tion events are more frequent in human females than in human
males. Additionally, our observations were consistent with
available data on sex-specific differences in the placement of
exchanges. On nearly all chromosome arms that we examined,
interstitially located foci predominated (Figure 2, Figure 3,
Figure 4, Figure 5, Figure 6, Figure 7). This finding agrees with
data from human genetic linkage analyses and previous immuno-
staining studies, which indicate that distal chromosome regions are
enriched for recombination in males by comparison with females
(e.g., [16]). Finally, consistent with previous MLH1-based data
[16],we observed significant among-individual variation in ex-
change frequencies, with mean MLH1 counts per cell ranging
from approximately 60 to 90. Similarly, previous linkage analyses
of genome-wide recombination levels in human females have also
identified significant individual to individual variation [30], albeit
not as pronounced as the differences that we observed.
Thus, in general, our observations on MLH1 foci reinforce
several previously reported features of human female recombina-
tion. However, there was one surprising difference between our
observations and previously reported genetic linkage data.
Specifically, our observation of low levels of MLH1-less bivalents
is in sharp contrast to previous chromosome-specific estimates of
exchangeless chromosomes from linkage analyses. For example,
Bugge et al [6] suggested that approximately 12% of chromosome
13 bivalents are achiasmate, while Oliver et al [15] recently
reported a value of 20% for chromosome 21. In contrast, in our
analysis only 1% of chromosome 13 bivalents and 5% of
chromosome 21 bivalents were lacking an MLH1 focus (Table 3).
Further, as discussed above, these values likely overestimate the
real frequency of MLH1-less bivalents, making the discrepancy
between the linkage and MLH1-based data even more puzzling.
While it is not possible to know with certainty which of these
estimates is ‘‘right’’, it is instructive to ask which – if either – data
set yields the better fit to available data on trisomies from human
pregnancies. Assuming random segregation of achiasmate biva-
lents, our MLH1 data suggest maternal nondisjunction rates of
approximately 0.5% for chromosome 13 and 2.5% for chromo-
somes 21, while the genetic linkage analyses suggest levels of 6%
for chromosome 13 [6] and 10% for chromosome 21 [15]. While
the actual incidence of trisomies 13 and 21 in human gametes and
pregnancies is not known, observations from oocytes, cleavage
stage embryos and clinically recognized pregnancies are much
closer to the MLH1-based estimates than those implied by the
Figure 4. Chromosomal locations of MLH1 foci on chromosome 17, considered by the number of MLH1 foci per SC.
doi:10.1371/journal.pgen.1000661.g004
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cleavage stage embryos suggest that trisomy 21 is more common
than trisomy 13, but neither condition occurs in more than about
5% of cases (e.g., [45,46,47,48]); and in clinically recognized
pregnancies, trisomies 13 and 21 account for only 0.2% and 0.5%
of cases, respectively [27]. Taken together, these data suggest that,
even in oocytes or very early stage embryos, the observed levels of
trisomies 13 and 21 are one-half or less that expected on the basis
of the linkage data. Thus, unless humans possess Drosophila-like
mechanisms to segregate achiasmate chromosomes (e.g., [49]), it
seems likely that MLH1-based assays are better predictors of
achiasmate levels than are linkage analyses.
Regardless of the correctness of this conclusion, the discrepant
observations beg another question – why do the two methods
differ in the first place? Specifically, why does a method that does
not capture all crossovers (MLH1 analysis) yield a lower estimate
of exchangeless bivalents than a method (linkage analysis) that
yields a higher overall level of genome-wide recombination? We
can think of a number of reasons why there might be differences
between the two approaches, but none of them adequately
explains available data on recombination and/or levels of human
trisomies. For example, it may be that there is significant
recombination-associated selection against a sub-set of oocytes,
so that these are eliminated and never contribute to pregnancies
(and consequently, are not represented in linkage data sets).
However, to reconcile the linkage and MLH1 data the selection
would have to favor oocytes with exchangeless bivalents, a
phenomenon that – at least on the surface – seems implausible.
Further, this has the effect of increasing the expected incidence of
trisomies in humans to levels that are simply unrealistic in the
absence of an achiasmate segregation mechanism; e.g., to over 5%
for trisomies 13 and 21. Second, because we selected the ‘‘best’’
oocytes (those with complete synapsis) for our studies, we may
have excluded oocytes with exchangeless bivalents. If these are
able to complete meiosis and are capable of being fertilized, the
number of zero exchange events might be much higher than we
have estimated (e.g., possibly as high as that associated with
linkage analysis). However, if this were the case, we are still left
with the discrepancy between the observed and expected incidence
of trisomies; i.e., the high estimates associated with linkage studies.
Third, it may be that a proportion of MLH1 foci do not give rise
to crossovers, meaning that we under-estimated the real number of
exchangeless homologs. However, if this were the case, the
problems associated with the above explanations still apply;
additionally, we are unaware of data from any species suggesting
that only some MLH1 foci contribute to crossovers. Finally, it may
be that, at least for some chromosomes, linkage analysis
systematically underestimates the actual number of exchanges.
For example, marker panels might not adequately cover all regions
(e.g., extremely distal or proximal segments), resulting in missed
Figure 5. Chromosomal locations of MLH1 foci on chromosome 18, considered by the number of MLH1 foci per SC.
doi:10.1371/journal.pgen.1000661.g005
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line with our observations it would create another problem, since
the discrepancy between the MLH1-based and linkage-based
estimates of genome-wide recombination estimates would be even
greater.
Thus, the reason for the discrepancy between the two
approaches is not immediately obvious. Clearly, it is important
that future analyses address this issue, since accurate data on the
number and chromosome-specific nature of exchangeless bivalents
is central to our understanding of human meiosis and mechanisms
of meiotic nondisjunction.
Are there chromosome-specific differences in the
frequency of ‘‘vulnerable’’ chiasma configurations?
Alterations in either the number or placement of recombination
events have been implicated in the genesis of all human trisomies
that have been appropriately studied. In general, these reports
suggest there are three types of chiasma configurations that
predispose to nondisjunction in humans: bivalents that have no
exchanges, bivalents with exchanges too far from the centromere,
and bivalents with exchanges too close to the centromere [14].
However, as outlined in Table 6, the nature of these alterations
varies for maternally-derived trisomies involving different chro-
mosomes.
Presumably, these chromosome-specific differences could orig-
inate in one of two ways. First, they could originate prenatally, at
the time that crossovers are formed. That is, it may be that the
likelihood of specific types of ‘‘vulnerable’’ chiasma configurations
varies among chromosomes and that, once established, similar
proportions of these are translated into nondisjunctional events. If
this is the case, the recombination patterns observed in linkage
analyses of individual trisomies should be reflected by the number
and chromosomal location of MLH1 foci in pachytene oocytes.
For example, for trisomy 18, achiasmate bivalents are an
important risk factor but ‘‘misplaced’’ (extremely proximal or
distal) exchanges are not; thus, in analyses of pachytene oocytes we
might expect to identify a relatively high proportion of MLH1-less
chromosome 18 bivalents but few, if any, with extremely proximal
or distal MLH1 foci.
Alternatively, it might be that the chromosome-specific
differences arise post-recombination in the adult ovary, with the
ability to process vulnerable chiasma configurations varying
among chromosomes. This might occur if chromosome-specific
differences in the distribution of repetitive elements affect the
binding of chromosome-associated proteins important for segre-
gation. For example, if the large block of heterochromatin on 16q
interferes with alignment of homologous centromeres on the
metaphase I plate, proximal exchanges might be more important
for segregation of chromosome 16 than for chromosome 17. In
this instance, there is no reason to invoke chromosome-specific
differences in the types or frequency of vulnerable chiasma
configurations in pachytene oocytes. Instead, the chromosome-
specific differences arise because of variation in the ability of
individual chromosomes to process sub-optimal chiasma configu-
rations.
Which, if either, of these alternatives fits the data from the
present study? For most trisomic situations it appears to be the
first, since the linkage results on trisomies are reflected by the
MLH1 data on pachytene oocytes. For example, in accordance
with the linkage data on trisomy 16, we found no evidence for
achiasmate chromosomes 16. For chromosome 18, the data from
trisomies predict a high proportion of achiasmate bivalents but no
unusually placed exchanges. Consistent with this prediction,
approximately 3% of bivalents lacked MLH1 foci and in a further
Figure 6. Chromosomal locations of MLH1 foci on chromosome
21, considered by the number of MLH1 foci per SC.
doi:10.1371/journal.pgen.1000661.g006
Figure 7. Chromosomal locations of MLH1 foci on chromosome
22, considered by the number of MLH1 foci per SC.
doi:10.1371/journal.pgen.1000661.g007
Recombination in Human Oocytes
PLoS Genetics | www.plosgenetics.org 10 September 2009 | Volume 5 | Issue 9 | e1000661Figure 8. Estimates of coincidence (and 95% confidence intervals) for intervals of different lengths on chromosomes 13, 16, 17, 18,
21, and 22. For this analysis, coincidence was defined as: Pr (MLH1 foci in both intervals)/Pr (MLH1 focus in interval 1)6Pr (MLH1 focus in interval 2).
Evidence for positive interference is denoted by coincidence values,1.0. For example, for chromosome 13, coincidence values were significantly
under 1.0 over one, two, and three intervals, indicating that the presence of an MLH1 focus inhibited the presence of a second focus over as many as
three intervals (e.g., from the p arm telomeric interval to the p arm proximal interval). Similarly, for chromosome 18 the effect extended over two
intervals (e.g., from the p arm telomeric interval to the p arm medial interval).
doi:10.1371/journal.pgen.1000661.g008
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further there was little evidence for extremely proximal or distal
exchanges. Finally, for chromosomes 21 and 22 we expected a
high incidence of achiasmate bivalents and these predictions were
met, with MLH1-less bivalents observed in no fewer than 4.9%
and 6.3% of cases, respectively.
Not all situations were as clear-cut. For example, we found no
evidence for ‘‘spikes’’ in the proportion of extremely distal or
proximal MLH1 foci on chromosome 21, despite the fact that
proximal and distal exchanges are associated with maternal
meiosis I and II-derived cases of trisomy 21 [13,15]. Additionally,
the proportion of MLH1-less chromosomes 13 was negligible,
despite the fact that an estimated 25–33% of maternally-derived
cases of trisomy 13 are thought to arise from achiasmate meioses
[3]. Thus, there was not complete concordance between the
MLH1 data on oocytes and the linkage data on trisomies.
Nevertheless, taken as a whole, the results provide strong evidence
that at least some of the chromosome-specific differences in
nondisjunction patterns are established during meiotic prophase
and, more generally, that some chromosomes are pre-disposed to
nondisjoin because of events that occurred in the fetal ovary. The
mechanisms by which these susceptibilities are ‘‘translated’’ into
nodisjunctional events years later are not clear, nor is the way in
which maternal age acts on the different aberrant exchange
configurations. For example, exchangeless bivalents presumably
impart a risk of nondisjunction regardless of maternal age, but the
effects of pericentromeric and telomeric exchanges on segregation
likely vary with age and among the different chromosomes.
Clearly, an eventual understanding of human nondisjunction will
require us to consider the effects of recombination and maternal
age separately for each chromosome, since it is now evident that




the Declaration of Helsinki. All procedures were approved by the
University of California-San Francisco, University of Washington
and Washington State University Institutional Review Boards, and
informed consent was obtained from all study participants.
Study population
The study material consisted of 1035 prophase oocytes from 31
fetal ovarian samples, with gestational ages ranging between 14–23
weeks, collected at the University of Washington Medical Center
in Seattle, Washington, or at the San Francisco General Hospital
Women’s Options Center in San Francisco, California (Table 1).
Typically, fetal ovaries were isolated and processed within 24
hours of the surgical procedure. Karyotypic information was
available on four cases, all of which had a 46,XX chromosome
complement; none of the other 27 cases were suspected to have a
chromosome abnormality.
Figure 9. Analysis of the location of adjacent short (p) arm and long (q) arm exchanges on chromosomes 16, 17, and 18. For bivalents
involving chromosomes 16, 17, and 18 in which we observed a single MLH1 focus on the p arm and a single MLH1 focus on the q arm, we examined
the location of the p arm focus (centomeric/proximal, medial or distal/telomeric), ordered by the location of the q arm focus.
doi:10.1371/journal.pgen.1000661.g009
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doi:10.1371/journal.pgen.1000661.t005
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From collection of sample material, tissues were processed using
a standard surface-spreading technique [50]. Briefly, the ovaries
were isolated and excess connective tissue removed. Each ovary
was placed in a sterile watch glass, covered in ,2 ml of a hypo-
extraction buffer (600 mM TRIS, 500 mM sucrose, 170 mM
citric acid, 500 mM EDTA, 500 mM DDT and 100 mM PMSF
in distilled water) and incubated at room temperature for
45 minutes. Each ovary was cut into two sections and each
section separately suspended in ,75 ml of 100 mM sucrose. After
macerating the ovarian tissue with needles, 10 ml aliquots of the
cell suspension were spread across glass slides coated with 2%
paraformaldehyde (pH 9.2). Slides were kept overnight in a
humidified chamber.
Slides were washed in 0.04% Photoflo
TM in double-distilled
water for 2 minutes and air-dried. The slides were then pre-
incubated for 20 minutes at room temperature in 16 antibody
dilution buffer (ADB). Sixty ml of an antibody cocktail consisting of
MLH1 (1:75; BD Pharmingen mouse anti-human) and CREST
(1:1,000; Fisher Scientific human anti-centromere) was applied to
the slides, which were then incubated overnight at 37uC. Sixty ml
of SYCP3 (1:150; Novus Biologicals rabbit anti-human polyclonal)
was added to the slides. The slides were covered with parafilm and
incubated for 2 hours at 37uC. Subsequently, the slides were
washed twice in 16 ADB for 20 minutes and a 60 ml cocktail
consisting of fluorescein anti-mouse (1:75) and CREST anti-
human (1:100) was added. Slides were incubated overnight at
37uC and 60 ml of rhodamine anti-rabbit (1:200) was added to the
slides. The slides were covered with parafilm and incubated for
45 minutes at 37uC; the slides were then washed twice in PBS. A
drop of FluoroGuard Antifade Reagent (BioRad Laboratories) was
added to the slides, which were kept at 4uC until viewing under
fluorescence optics. Slides were evaluated on a Zeiss epifluores-
cence microscope, images captured and cell coordinates noted for
subsequent fluorescence in situ hybridization (FISH) analysis (see
below).
Fluorescence in situ hybridization (FISH)
Chromosome-specific FISH was performed on slides that
contained meiotic cells with robust MLH1 and CREST signals
on initial analysis. Specifically, we used TelVysion13-Spectrum
Orange, CEP16-SpectrumGreen, TelVysion17-SpectrumGreen,
TelVysion18-SpectrumOrange, TelVysion21-SpectrumOrange
and TelVysion22-SpectrumOrange (Vysis). Briefly, previously
immunostained slides were dehydrated in an ethanol series
(75%, 95% and 100%) at room temperature, denatured in 70%
formamide/26SSC at 73uC for 5 minutes and again dehydrated
in an ethanol series (75%, 95% and 100%) at room temperature.
The probe mix was denatured using the same settings except for
the dehydration step. The probe mix was then added to the slides,
which were kept in a humidified chamber at 37uC overnight.
Slides were briefly washed in 0.46SSC, 26SSC/1% NP-40 and
distilled water for 10 seconds, 3 seconds and 1 second, respec-
tively, air-dried and stained with Vectashield (Vector Laboratories)
and analyzed using fluorescence optics. Cells that had previously
been analyzed in immunostaining studies were located, and FISH
images captured.
Cytological analysis
In determining the number and location of MLH1 foci in
pachytene oocytes, we restricted our analyses to cells in which
synapsis was complete, or nearly so, and to cells with MLH1
signals of robust size, shape, staining intensity and association with
the synaptonemal complex (SC). All such cells were scored, with
no attempt made to restrict our analysis to cells with an arbitrary
minimum number of MLH1 foci. Apparent MLH1 signals that
were observed at overlapping locations between two or more SCs
were not counted; additionally, to be considered as separate foci,
we required that the space between adjacent MLH signals be
equal to at least one MLH1 signal domain. All cells were scored by
at least two observers; in the event of discrepancies, the cells were
omitted.
For analyses of individual chromosomes, we used FISH to
analyze approximately 100 cells for six chromosomes (13, 16, 17,
18, 21 and 22) from a subset of seven representative cases (EC 69,
76, 91, 96, 98, 99 and 101). FISH-identified SCs involving
chromosomes 13, 16, 17, 18, 21 and 22 were analyzed by counting
the number of MLH1 foci per SC and per SC arm (p-arm and q-
arm). Each SC arm was arbitrarily divided into five segments of
equal length (centromeric, proximal, medial, distal and telomeric)
and the number and location of MLH1 foci along the SC
recorded.
Analysis of interference
We define the coincidence for the pair of intervals (i, j)t ob e
Cij=pij/(pi pj), where pij is the probability of crossovers (MLH1
foci) in both intervals i and j, and pi is the probability of a crossover
in interval i. (There were few instances of multiple crossovers
within an interval, and so we will define coincidence using the
probabilities of at least one crossover in the respective intervals.)
Let pi and pij denote our estimates of pi and pij, respectively (that is,
the observed proportions of meioses with crossovers in the interval








13 yes no no Estimated 25–33% of cases associated with achiasmate bivalents (2, 3)
16 no yes no No known contribution of achiasmate bivalents, but distally located exchanges
reported for most cases (5, T. Hassold and H. Hall, unpublished observations)
17 unknown unknown unknown ‘‘Rare’’ trisomy; no available information on origin
18 yes no no Estimated 30% of cases associated with achiasmate bivalents (6)
21 yes yes yes Estimated 40% of cases involve achiasmate bivalents; distally located exchanges
important contributor to meiosis I cases and proximal exchanges important to
apparent meiosis II cases (7, 8)
22 yes no no Estimated 25% of cases associated with achiasmate bivalents (9)
doi:10.1371/journal.pgen.1000661.t006
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independence (no crossover interference), while in the case of
positive crossover interference, coincidence will be ,1. With the
assumption that the coincidence is constant for pairs of intervals
that are a given distance apart, we estimate the coincidence to be
Spij/S(pi pj), where the sums are over pairs of intervals that are
separated by a fixed distance. This estimate is similar to taking the
average of the individual estimates, pij/(pi pj), but the ratio of the
sums provides a more stable estimate (that is, one with a smaller
standard error); this was confirmed by computer simulations.
Confidence intervals for the coincidence values were derived by
a nonparametric bootstrap [51]. That is, we sampled with
replacement from the observed set of meioses to obtain a new
data set of the same size (with some meioses omitted and some
repeated multiple times), estimated the coincidence for all possible
distances between intervals, and repeated this process 10,000
times. The interval defined by the 2.5 and 97.5 percentiles of the
coincidence estimates across bootstrap replicates provides an
approximate 95% confidence interval.
Supporting Information
Figure S1 Distribution of the number of MLH1 foci/cell for
1,035 pachytene oocytes from 31 fetal ovarian samples.
Found at: doi:10.1371/journal.pgen.1000661.s001 (4.66 MB TIF)
Figure S2 Chromosomal locations of MLH1 foci on chromo-
somes 13; data represent pooled observations from seven fetal
ovarian samples (EC 69, 76, 91, 96, 98, 99, and 101). For each
chromosome, the data are grouped by the number of MLH1 foci
per bivalent, and second pooled for all the individual groups;
n=the number of cells. For example, for chromosome 13, 8 cells
had a single MLH1 focus, 42 cells had two foci, 39 had three foci
and 14 cells had four or five foci; in total, we examined the
distribution of MLH1 foci on chromosome 13 in 103 cells.
Found at: doi:10.1371/journal.pgen.1000661.s002 (3.71 MB TIF)
Figure S3 Chromosomal locations of MLH1 foci on chromo-
some 16; see Figure S2 legend.
Found at: doi:10.1371/journal.pgen.1000661.s003 (4.04 MB TIF)
Figure S4 Chromosomal locations of MLH1 foci on chromo-
some 17; see Figure S2 legend.
Found at: doi:10.1371/journal.pgen.1000661.s004 (1.43 MB TIF)
Figure S5 Chromosomal locations of MLH1 foci on chromo-
some 18; see Figure S2 legend.
Found at: doi:10.1371/journal.pgen.1000661.s005 (1.44 MB TIF)
Figure S6 Chromosomal locations of MLH1 foci on chromo-
some 21; see Figure S2 legend.
Found at: doi:10.1371/journal.pgen.1000661.s006 (3.04 MB TIF)
Figure S7 Chromosomal locations of MLH1 foci on chromo-
some 22; see Figure S2 legend.
Found at: doi:10.1371/journal.pgen.1000661.s007 (3.10 MB TIF)
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